United States Phenylketonuria Drug Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Phenylketonuria Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Phenylketonuria Drug Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Phenylketonuria Drug Overall Market Size
2.1 United States Phenylketonuria Drug Market Size: 2021 VS 2027
2.2 United States Phenylketonuria Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Phenylketonuria Drug Sales: 2016-2027
3 Company Landscape
3.1 Top Phenylketonuria Drug Players in United States Market
3.2 Top United States Phenylketonuria Drug Companies Ranked by Revenue
3.3 United States Phenylketonuria Drug Revenue by Companies
3.4 United States Phenylketonuria Drug Sales by Companies
3.5 United States Phenylketonuria Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Phenylketonuria Drug Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Phenylketonuria Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Phenylketonuria Drug Players in United States Market
3.8.1 List of Tier 1 Phenylketonuria Drug Companies in United States
3.8.2 List of Tier 2 and Tier 3 Phenylketonuria Drug Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Phenylketonuria Drug Market Size Markets, 2021 & 2027
4.1.2 Medications
4.1.3 Supplements
4.1.4 Others
4.2 By Type - United States Phenylketonuria Drug Revenue & Forecasts
4.2.1 By Type - United States Phenylketonuria Drug Revenue, 2016-2021
4.2.2 By Type - United States Phenylketonuria Drug Revenue, 2022-2027
4.2.3 By Type - United States Phenylketonuria Drug Revenue Market Share, 2016-2027
4.3 By Type - United States Phenylketonuria Drug Sales & Forecasts
4.3.1 By Type - United States Phenylketonuria Drug Sales, 2016-2021
4.3.2 By Type - United States Phenylketonuria Drug Sales, 2022-2027
4.3.3 By Type - United States Phenylketonuria Drug Sales Market Share, 2016-2027
4.4 By Type - United States Phenylketonuria Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Phenylketonuria Drug Market Size, 2021 & 2027
5.1.2 Household
5.1.3 Hospital
5.1.4 Others
5.2 By Application - United States Phenylketonuria Drug Revenue & Forecasts
5.2.1 By Application - United States Phenylketonuria Drug Revenue, 2016-2021
5.2.2 By Application - United States Phenylketonuria Drug Revenue, 2022-2027
5.2.3 By Application - United States Phenylketonuria Drug Revenue Market Share, 2016-2027
5.3 By Application - United States Phenylketonuria Drug Sales & Forecasts
5.3.1 By Application - United States Phenylketonuria Drug Sales, 2016-2021
5.3.2 By Application - United States Phenylketonuria Drug Sales, 2022-2027
5.3.3 By Application - United States Phenylketonuria Drug Sales Market Share, 2016-2027
5.4 By Application - United States Phenylketonuria Drug Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Biomarin
6.1.1 Biomarin Corporation Information
6.1.2 Biomarin Overview
6.1.3 Biomarin Phenylketonuria Drug Sales and Revenue in United States Market (2016-2021)
6.1.4 Biomarin Phenylketonuria Drug Product Description
6.1.5 Biomarin Recent Developments
6.2 Vitaflo
6.2.1 Vitaflo Corporation Information
6.2.2 Vitaflo Overview
6.2.3 Vitaflo Phenylketonuria Drug Sales and Revenue in United States Market (2016-2021)
6.2.4 Vitaflo Phenylketonuria Drug Product Description
6.2.5 Vitaflo Recent Developments
6.3 Mead Johnson
6.3.1 Mead Johnson Corporation Information
6.3.2 Mead Johnson Overview
6.3.3 Mead Johnson Phenylketonuria Drug Sales and Revenue in United States Market (2016-2021)
6.3.4 Mead Johnson Phenylketonuria Drug Product Description
6.3.5 Mead Johnson Recent Developments
6.4 Nutricia
6.4.1 Nutricia Corporation Information
6.4.2 Nutricia Overview
6.4.3 Nutricia Phenylketonuria Drug Sales and Revenue in United States Market (2016-2021)
6.4.4 Nutricia Phenylketonuria Drug Product Description
6.4.5 Nutricia Recent Developments
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Overview
6.5.3 Abbott Phenylketonuria Drug Sales and Revenue in United States Market (2016-2021)
6.5.4 Abbott Phenylketonuria Drug Product Description
6.5.5 Abbott Recent Developments
6.6 Dr. Schar
6.6.1 Dr. Schar Corporation Information
6.6.2 Dr. Schar Overview
6.6.3 Dr. Schar Phenylketonuria Drug Sales and Revenue in United States Market (2016-2021)
6.6.4 Dr. Schar Phenylketonuria Drug Product Description
6.6.5 Dr. Schar Recent Developments
6.7 Prominmetabolics
6.7.1 Prominmetabolics Corporation Information
6.7.2 Prominmetabolics Overview
6.7.3 Prominmetabolics Phenylketonuria Drug Sales and Revenue in United States Market (2016-2021)
6.7.4 Prominmetabolics Phenylketonuria Drug Product Description
6.7.5 Prominmetabolics Recent Developments
6.8 Cambrooke
6.8.1 Cambrooke Corporation Information
6.8.2 Cambrooke Overview
6.8.3 Cambrooke Phenylketonuria Drug Sales and Revenue in United States Market (2016-2021)
6.8.4 Cambrooke Phenylketonuria Drug Product Description
6.8.5 Cambrooke Recent Developments
6.9 Juvela
6.9.1 Juvela Corporation Information
6.9.2 Juvela Overview
6.9.3 Juvela Phenylketonuria Drug Sales and Revenue in United States Market (2016-2021)
6.9.4 Juvela Phenylketonuria Drug Product Description
6.9.5 Juvela Recent Developments
6.10 Firstplay Dietary
6.10.1 Firstplay Dietary Corporation Information
6.10.2 Firstplay Dietary Overview
6.10.3 Firstplay Dietary Phenylketonuria Drug Sales and Revenue in United States Market (2016-2021)
6.10.4 Firstplay Dietary Phenylketonuria Drug Product Description
6.10.5 Firstplay Dietary Recent Developments
7 United States Phenylketonuria Drug Production Capacity, Analysis
7.1 United States Phenylketonuria Drug Production Capacity, 2016-2027
7.2 Phenylketonuria Drug Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Phenylketonuria Drug Supply Chain Analysis
9.1 Phenylketonuria Drug Industry Value Chain
9.2 Phenylketonuria Drug Upstream Market
9.3 Phenylketonuria Drug Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Phenylketonuria Drug Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Phenylketonuria Drug in United States Market
Table 2. Top Phenylketonuria Drug Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Phenylketonuria Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Phenylketonuria Drug Revenue Share by Companies, 2016-2021
Table 5. United States Phenylketonuria Drug Sales by Companies, (K Pcs), 2016-2021
Table 6. United States Phenylketonuria Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Phenylketonuria Drug Price (2016-2021) & (USD/Pcs)
Table 8. Manufacturers Phenylketonuria Drug Product Type
Table 9. List of Tier 1 Phenylketonuria Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Phenylketonuria Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Medications
Table 12. Major Manufacturers of Supplements
Table 13. By Type - United States Phenylketonuria Drug Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Phenylketonuria Drug Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Phenylketonuria Drug Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Phenylketonuria Drug Sales (K Pcs), 2016-2021
Table 17. By Type - United States Phenylketonuria Drug Sales (K Pcs), 2022-2027
Table 18. By Application - United States Phenylketonuria Drug Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Phenylketonuria Drug Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Phenylketonuria Drug Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Phenylketonuria Drug Sales (K Pcs), 2016-2021
Table 22. By Application - United States Phenylketonuria Drug Sales (K Pcs), 2022-2027
Table 23. Biomarin Corporation Information
Table 24. Biomarin Description and Major Businesses
Table 25. Biomarin Phenylketonuria Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 26. Biomarin Phenylketonuria Drug Product
Table 27. Biomarin Recent Developments
Table 28. Vitaflo Corporation Information
Table 29. Vitaflo Description and Major Businesses
Table 30. Vitaflo Phenylketonuria Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 31. Vitaflo Phenylketonuria Drug Product
Table 32. Vitaflo Recent Developments
Table 33. Mead Johnson Corporation Information
Table 34. Mead Johnson Description and Major Businesses
Table 35. Mead Johnson Phenylketonuria Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 36. Mead Johnson Phenylketonuria Drug Product
Table 37. Mead Johnson Recent Developments
Table 38. Nutricia Corporation Information
Table 39. Nutricia Description and Major Businesses
Table 40. Nutricia Phenylketonuria Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 41. Nutricia Phenylketonuria Drug Product
Table 42. Nutricia Recent Developments
Table 43. Abbott Corporation Information
Table 44. Abbott Description and Major Businesses
Table 45. Abbott Phenylketonuria Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 46. Abbott Phenylketonuria Drug Product
Table 47. Abbott Recent Developments
Table 48. Dr. Schar Corporation Information
Table 49. Dr. Schar Description and Major Businesses
Table 50. Dr. Schar Phenylketonuria Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 51. Dr. Schar Phenylketonuria Drug Product
Table 52. Dr. Schar Recent Developments
Table 53. Prominmetabolics Corporation Information
Table 54. Prominmetabolics Description and Major Businesses
Table 55. Prominmetabolics Phenylketonuria Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 56. Prominmetabolics Phenylketonuria Drug Product
Table 57. Prominmetabolics Recent Developments
Table 58. Cambrooke Corporation Information
Table 59. Cambrooke Description and Major Businesses
Table 60. Cambrooke Phenylketonuria Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 61. Cambrooke Phenylketonuria Drug Product
Table 62. Cambrooke Recent Developments
Table 63. Juvela Corporation Information
Table 64. Juvela Description and Major Businesses
Table 65. Juvela Phenylketonuria Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 66. Juvela Phenylketonuria Drug Product
Table 67. Juvela Recent Developments
Table 68. Firstplay Dietary Corporation Information
Table 69. Firstplay Dietary Description and Major Businesses
Table 70. Firstplay Dietary Phenylketonuria Drug Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 71. Firstplay Dietary Phenylketonuria Drug Product
Table 72. Firstplay Dietary Recent Developments
Table 73. Phenylketonuria Drug Production Capacity (K Pcs) of Key Manufacturers in United States Market, 2019-2021 (K Pcs)
Table 74. United States Phenylketonuria Drug Capacity Market Share of Key Manufacturers, 2019-2021
Table 75. Phenylketonuria Drug Market Opportunities & Trends in United States Market
Table 76. Phenylketonuria Drug Market Drivers in United States Market
Table 77. Phenylketonuria Drug Market Restraints in United States Market
Table 78. Phenylketonuria Drug Raw Materials
Table 79. Phenylketonuria Drug Raw Materials Suppliers in United States Market
Table 80. Typical Phenylketonuria Drug Downstream
Table 81. Phenylketonuria Drug Downstream Clients in United States Market
Table 82. Phenylketonuria Drug Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Phenylketonuria Drug Product Picture
Figure 2. Phenylketonuria Drug Segment by Type
Figure 3. Phenylketonuria Drug Segment by Application
Figure 4. United States Phenylketonuria Drug Market Overview: 2020
Figure 5. United States Phenylketonuria Drug Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Phenylketonuria Drug Revenue, 2016-2027 (US$, Mn)
Figure 7. Phenylketonuria Drug Sales in United States Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Phenylketonuria Drug Revenue in 2020
Figure 9. Medications Product Picture
Figure 10. Supplements Product Picture
Figure 11. Others Product Picture
Figure 12. By Type - United States Phenylketonuria Drug Sales Market Share, 2016-2027
Figure 13. By Type - United States Phenylketonuria Drug Revenue Market Share, 2016-2027
Figure 14. By Type - United States Phenylketonuria Drug Price (USD/Pcs), 2016-2027
Figure 15. Household
Figure 16. Hospital
Figure 17. Others
Figure 18. By Application - United States Phenylketonuria Drug Sales Market Share, 2016-2027
Figure 19. By Application - United States Phenylketonuria Drug Revenue Market Share, 2016-2027
Figure 20. By Application - United States Phenylketonuria Drug Price (USD/Pcs), 2016-2027
Figure 21. Biomarin Phenylketonuria Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Vitaflo Phenylketonuria Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Mead Johnson Phenylketonuria Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Nutricia Phenylketonuria Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Abbott Phenylketonuria Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Dr. Schar Phenylketonuria Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Prominmetabolics Phenylketonuria Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Cambrooke Phenylketonuria Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Juvela Phenylketonuria Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. Firstplay Dietary Phenylketonuria Drug Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. United States Phenylketonuria Drug Production Capacity (K Pcs), 2016-2027
Figure 32. Phenylketonuria Drug Industry Value Chain
Figure 33. Marketing Channels